Clinical Registries
3 min read

Key Takeaways
GWTG Heart Failure exists to close the gap between guideline evidence and what patients actually receive, a gap that once meant one in three heart failure patients died within a year of hospitalization.
It hinges on three moving targets: guideline-directed medical therapy that expands with each cycle, ejection fraction values usually outside the current admission, and eligibility that depends on judgment calls about comorbidities.
An abstractor trained two years ago may be applying medication-class rules that have since changed.
AI-guided abstraction cleared a heart failure backlog at Froedtert, freeing a senior data manager for quality improvement work. White Plains Hospital held validated accuracy above 98% on the same registry.
Heart failure is high-volume and readmission-sensitive, so delayed data costs the window in which a team could still act on it.
Inside the Work Behind GWTG Heart Failure Registry Data
The American Heart Association launched Get With The Guidelines Heart Failure in 2005 to close the gap between what the evidence showed and what patients actually received. At the time, roughly one in three heart failure patients died within a year of hospitalization, and much of the therapy known to help them wasn't reaching the bedside.
Two decades and nearly 3 million patient records later, the registry still comes down to the same question for every patient: did they leave the hospital on the therapy the guidelines call for. Answering that requires an abstractor to confirm a medication list, locate a clinical value recorded somewhere other than this admission and determine whether the patient qualified for the measure at all.
This is the final post in a series looking at what registry-specific abstraction actually demands. For the bigger picture on why registries are more valuable than ever and where the strain is coming from, see Clinical Registries Are More Valuable Than Ever. The Work Behind Them Is Under Strain.
Guideline-Directed Medical Therapy Is a Moving Target
Guideline-directed medical therapy sits at the center of the registry. The drug classes that count have expanded across recent guideline cycles as evidence has accumulated.
An abstractor trained two years ago may be applying a definition that has since changed. Confirming therapy at discharge means checking the current guideline version against the discharge medication record, then determining whether an absence reflects a gap in care or a documented contraindication.
Quality teams absorb that maintenance work on top of abstraction itself. Someone tracks each specification update and retrains the team on what moved.
Finding Ejection Fraction Means Looking Backward
The ejection fraction value the registry requires rarely appears in the discharge documentation.
It is recorded in an echocardiogram or catheterization report, often dated before this admission and sometimes documented during a different encounter entirely. The abstractor locates the most recent result, confirms it remains the current value on file and carries it forward.
This work means searching backward through a patient's history, across multiple stays.
Comorbidities Make Eligibility a Judgment Call Before Abstraction Begins
Most heart failure patients arrive with additional conditions that shape their eligibility for the registry, most commonly:
Atrial fibrillation
Chronic kidney disease
Diabetes
Each can affect which measures apply and which exclusions are relevant. Determining eligibility means reading the documentation and applying clinical definitions before any variable gets abstracted.
Delayed Heart Failure Data Costs More Than Delayed Reporting
Heart failure is high volume and readmission-sensitive, which makes it one of the registries where the lag between the encounter and the insight matters most.
A quality team that identifies a discharge medication gap three months later has lost the window in which a documentation fix or a process change would have reached the patients it was meant to help. Even if the registry reports accurately, it is reporting on a period the team can no longer influence.
How Layer Health Handles GWTG Heart Failure
Layer Health reads the complete longitudinal record and surfaces:
The ejection fraction value, with the report it came from
Discharge medication evidence
Comorbidity documentation bearing on eligibility
Each comes with its source and a suggested answer. The abstractor still decides whether a missing medication reflects a gap in care or a documented contraindication, and whether a comorbidity actually changes eligibility.
At Froedtert & the Medical College of Wisconsin, a growing heart failure registry backlog had reached the point where leadership pulled a senior data manager away from her quality improvement work to help clear it. AI-guided abstraction:
Cut her time per case enough to clear the backlog
Returned her to the dashboards and pathway analyses the registry data exists to support
Matched or exceeded human accuracy across both structured and unstructured fields
Validation also surfaced a workflow gap the team did not know about. One abstractor had been completing fields no longer required for her submission type, a holdover from an outdated specification. Fixing it compounded the time savings across every case that followed.

